GAM
DFTX

Gotham Asset Management’s Definium Therapeutics DFTX Stock Holding History

Gotham Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,825
Closed -$239K – 1825
2025
Q4 		$239K Buy
17,825
+823
+5% +$10.2K ﹤0.01% 1626
2025
Q3 		$200K Buy
17,002
+2,924
+21% +$27.3K ﹤0.01% 1616
2025
Q2 		$91.4K Buy
+14,078
New +$92.6K ﹤0.01% 1620

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gotham Asset Management's DFTX Position: Q1 2026 in Review

Gotham Asset Management sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 17,825 shares — an estimated $239K sold.

Gotham Asset Management first reported a position in DFTX in Q2 2025 and held it in 3 quarters. The position peaked at $239K in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Gotham Asset Management reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Gotham Asset Management sold 17,825 Definium Therapeutics shares in Q1 2026, an estimated $239K.
  • Gotham Asset Management first reported a position in Definium Therapeutics in Q2 2025 and held it in 3 quarters.
  • Gotham Asset Management's Definium Therapeutics position peaked at $239K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.